A follow-on study to evaluate the safety of re-administration of adeno-associated viral vector containing the gene for human RPE65 [AAV2-hRPE65v2] to the contralateral eye in subjects with leber congenital amaurosis (LCA) previously enrolled in a phase 1 study. Here, RPE65 is linked to Leber congenital amaurosis.